Support Insurance Coverage for Clinical Trial Participation
Participation in a clinical trial can bring new hope to people battling cancer – and it paves the way for the treatments that will save people’s lives tomorrow. But today many health insurers refuse to pay for routine care costs when patients enter a clinical trial. That practice must stop.
Sen. Sherrod Brown and Rep. Steve Israel have introduced The Access to Cancer Clinical Trials Act (S. 488/H.R. 716) in the Senate and the House of Representatives that would prevent health insurance plans – both state-based and employer-funded (ERISA) plans – from denying patients enrolled in clinical trials services that would be covered under their insurance plan as normal “routine care.” This legislation would remove a major barrier toward patient enrollment in clinical trials. Contact your elected officials and ask them to co-sponsor S. 488/H.R. 716 now!
Send a Letter to Your Rep! |
Send a Letter to Your Senator! |
